Atea Pharmaceuticals, Inc. SEC filings

Filings

Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.

1. ROUTINESCHEDULE 13GAtea Pharmaceuticals, Inc.AVIROct 8

   Atea Pharmaceuticals, Inc. (AVIR) reports 6.0% stake

   • Tang Capital Management, LLC holds 4,814,700 shares
   • Kevin Tang and other entities hold 4,814,700 shares
   • Total stake is 6.0% of outstanding shares

   TANG CAPITAL MANAGEMENT LLC, filed by

2. NOTABLE10-QAtea Pharmaceuticals, Inc.AVIRAug 12

   Quarterly report

3. ROUTINE8-KAtea Pharmaceuticals, Inc.AVIRAug 12

   Current report

4. ROUTINE4Atea Pharmaceuticals, Inc.AVIRJun 23

   8 insider filings

   Howard Berman, insider filing for AVIR

   Show all 8

   • 4Insider filing for AVIRJun 23
   • 4Insider filing for AVIRJun 23
   • 4Insider filing for AVIRJun 23
   • 4Insider filing for AVIRJun 23
   • 4Insider filing for AVIRJun 23
   • 4Insider filing for AVIRJun 23
   • 4Insider filing for AVIRJun 23
   • 4Insider filing for AVIRJun 23

   Howard Berman, reporting

5. ROUTINE8-KAtea Pharmaceuticals, Inc.AVIRJun 22

   Current report

6. ROUTINE4/AAtea Pharmaceuticals, Inc.AVIRMay 21

   Polly A. Murphy, insider filing for AVIR (amended)

   Polly A. Murphy, reporting

7. ROUTINE4Atea Pharmaceuticals, Inc.AVIRMay 20

   Polly A. Murphy, insider filing for AVIR

   Polly A. Murphy, reporting

8. NOTABLE10-QAtea Pharmaceuticals, Inc.AVIRMay 12

   Quarterly report

9. ROUTINE8-KAtea Pharmaceuticals, Inc.AVIRMay 12

   Current report

10. ROUTINESCHEDULE 13G/AAtea Pharmaceuticals, Inc.AVIRMay 6

    Ownership stake disclosure by FMR LLC (amended)

    FMR LLC, filed by

11. ROUTINEDEFA14AAtea Pharmaceuticals, Inc.AVIRApr 27

    Additional proxy materials

12. ROUTINEDEF 14AAtea Pharmaceuticals, Inc.AVIRApr 27

    Proxy statement

13. ROUTINESCHEDULE 13G/AAtea Pharmaceuticals, Inc.AVIRMar 26

    Ownership stake disclosure by VANGUARD GROUP INC (amended)

    VANGUARD GROUP INC, filed by

14. ROUTINE4Atea Pharmaceuticals, Inc.AVIRMar 13

    Andrea Corcoran, insider filing for AVIR

    Andrea Corcoran, reporting

15. NOTABLE10-KAtea Pharmaceuticals, Inc.AVIRMar 5

    Annual report

16. ROUTINE8-KAtea Pharmaceuticals, Inc.AVIRMar 5

    Current report

17. ROUTINESCHEDULE 13GAtea Pharmaceuticals, Inc.AVIRFeb 9

    Ownership stake disclosure by BML Investment Partners, L.P.

    BML Investment Partners, L.P., filed by

18. ROUTINE4Atea Pharmaceuticals, Inc.AVIRFeb 3

    6 insider filings

    Maria Arantxa Horga, insider filing for AVIR

    Show all 6

    • 4Insider filing for AVIRFeb 3
    • 4Insider filing for AVIRFeb 3
    • 4Insider filing for AVIRFeb 3
    • 4Insider filing for AVIRFeb 3
    • 4Insider filing for AVIRFeb 3
    • 4Insider filing for AVIRFeb 3

    Maria Arantxa Horga, reporting

19. ROUTINE8-KAtea Pharmaceuticals, Inc.AVIRJan 8

    Current report

20. ROUTINESCHEDULE 13G/AAtea Pharmaceuticals, Inc.AVIRDec 5, 2025

    Ownership stake disclosure by FMR LLC (amended)

    FMR LLC, filed by

21. NOTABLE10-QAtea Pharmaceuticals, Inc.AVIRNov 12, 2025

    Quarterly report

22. ROUTINE8-KAtea Pharmaceuticals, Inc.AVIRNov 12, 2025

    Current report

Older filings on EDGAR